Home › NDC Lookup › RxCUI directory › RxCUI 310994

Infliximab 100 MG Injection — RxCUI 310994

Name: Infliximab 100 MG Injection (RxCUI 310994)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 310994 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI310994

Official nameInfliximab 100 MG Injection

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asinfliximab 100 MG per 10 ML Injection

FDA products mapped2

Package NDCs mapped2

Reported Medicaid activity (SDUD)56,168 prescriptions · 50 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Infliximab Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Infliximab is a biologic medication — a lab-made protein — that calms down the part of your immune system driving inflammation. It's given through an IV (into a vein) at an infusio...
What exactly is infliximab and how is it given to me?
The most common ones are infections — especially upper respiratory infections like colds or sinusitis — and infusion reactions, which can include flushing, headache, chills, or a r...
What are the most common side effects I should expect?

📖 Read our full Infliximab Injection guide →

🕸️ Concept Web — How Infliximab 100 MG Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Infliximab 100 MG Injection RxCUI 310994 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Infliximab 191831 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Remicade 219610 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Infliximab Injection 1655941 SCDF
- Infliximab Injectable Product 1160692 SCDG
- Infliximab Injection [Remicade] 1655944 SBDF
- Remicade Injectable Product 1180726 SBDG
- Injection 1649574 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Infliximab 100 MG 1655940 SCDC
- Infliximab 100 MG Injection [Remicade] 213361 SBD
- Infliximab 100 MG [Remicade] 1655943 SBDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Infliximab 100 MG SCDC · 1655940
Infliximab Injection SCDF · 1655941
Infliximab Injectable Product SCDG · 1160692

Brand-Name Concepts

Infliximab 100 MG Injection [Remicade] SBD · 213361
Infliximab 100 MG [Remicade] SBDC · 1655943
Infliximab Injection [Remicade] SBDF · 1655944
Remicade Injectable Product SBDG · 1180726
Remicade BN · 219610

📦 FDA Products & Package NDCs

2 products · 2 package NDCs

2 package NDCs map to RxCUI 310994 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
57894-0030-01	1 VIAL, SINGLE-USE in 1 BOX (57894-030-01) / 10 mL in 1 VIA...	REMICADE	Janssen Biotech, Inc.	1998-08-24
57894-0160-01	1 VIAL, SINGLE-USE in 1 BOX (57894-160-01) / 10 mL in 1 VIA...	INFLIXIMAB	Janssen Biotech, Inc.	2021-10-05

Observed labelers: Janssen Biotech, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.

Per ea · median

$1,135.9700

Range $1,135.9700–$1,135.9700 · middle 50% $1,135.9700–$1,135.9700 · 1 NDCs

Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J1745	Infliximab not biosimil 10mg	2	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.